Boston Scientific (FRA:BSX) Additional Paid-In Capital : €18,933 Mil(As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Additional Paid-In Capital?

Boston Scientific's quarterly additional paid-in capital increased from Jun. 2023 (€18,867 Mil) to Sep. 2023 (€19,277 Mil) but then stayed the same from Sep. 2023 (€19,277 Mil) to Dec. 2023 (€18,933 Mil).

Boston Scientific's annual additional paid-in capital increased from Dec. 2021 (€17,688 Mil) to Dec. 2022 (€19,153 Mil) but then declined from Dec. 2022 (€19,153 Mil) to Dec. 2023 (€18,933 Mil).

Boston Scientific Additional Paid-In Capital Historical Data

The historical data trend for Boston Scientific's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Additional Paid-In Capital Chart

Boston Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

15,804.90

16,219.70

17,687.61

19,152.82

18,933.30

Boston Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															19,012.50	18,867.04	19,276.90	18,933.30	-

Boston Scientific Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Boston Scientific Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Boston Scientific (FRA:BSX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (FRA:BSX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BSX:USA BSX:Mexico 1BSX:Italy B1SX34:Brazil BSXC:Austria

Address

300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234

Website

https://www.bostonscientific.com

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.